The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study of 2nd-line FOLFIRI versus modified FOLFIRI with PARP inhibitor ABT-888 (veliparib) (NSC-737664) in metastatic pancreatic cancer (mPC): SWOG S1513.
 
E. Gabriela Chiorean
Consulting or Advisory Role - Genentech/Roche; Merrimack; Novocure; Pfizer; Pfizer
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Ignyta; Incyte; Newlink Genetics; PRISM Pharma; Spectrum Pharmaceuticals; Stemline Therapeutics
Travel, Accommodations, Expenses - Celgene
 
Shannon McDonough
No Relationships to Disclose
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - Celgene; emd serono; Halozyme; Roche; sanofi
 
Elizabeth M. Swisher
No Relationships to Disclose
 
Michael J. Pishvaian
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
Honoraria - Caris Life Sciences; Celgene; Sirtex Medical
Consulting or Advisory Role - Caris Life Sciences; Celgene; Perthera; Sirtex Medical
Speakers' Bureau - Caris Life Sciences; Sirtex Medical
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Celldex (Inst); FibroGen (Inst); Genentech (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Perthera
 
Katherine Guthrie
No Relationships to Disclose
 
Andrew M. Lowy
Consulting or Advisory Role - Halozyme; Merck
Research Funding - Mitsubishi Tanabe Pharma; Syros Pharmaceuticals
Expert Testimony - Merck
Travel, Accommodations, Expenses - Pfizer
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical